The ODT Community Pharmacy Program aims to improve access to and affordability of opioid dependence treatment within the community pharmacy sector by supporting the delivery of pharmacy services including the staged supply of these medicines and, subject to state and territory legislation and guidelines, pharmacist administration of buprenorphine injections. The ODT Community Pharmacy Program allows participating Section 90 pharmacies to submit claims for eligible oral/sublingual and long acting injectable ODT medications.
Click here for full details of the ODT Program, including the program rules.